Ángela Cano

Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial

José Molina, Enrique Montero-Mateos, Julia Praena‐Segovia et al. · Clinical Microbiology and Infection · 2021 · 136 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Validation of Scores and Proposal for Management

Ángela Cano, Belén Gutiérrez‐Gutiérrez, Isabel Machuca et al. · Clinical Infectious Diseases · 2017 · 110 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems

Isabel Machuca, Belén Gutiérrez‐Gutiérrez, Irene Gracia-Ahufinger et al. · Antimicrobial Agents and Chemotherapy · 2017 · 76 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17

Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial

Aurora Páez-Vega, Belén Gutiérrez‐Gutiérrez, M.L. Agüera et al. · Clinical Infectious Diseases · 2021 · 68 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

Juan José Castón, Ángela Cano, Inés Pérez‐Camacho et al. · Journal of Antimicrobial Chemotherapy · 2022 · 66 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17